Fig. 1: Plasma levels of AEA and 2-AG before and after VLCD
From: Caloric restriction lowers endocannabinoid tonus and improves cardiac function in type 2 diabetes

Change in AEA (a) and 2-AG (b). *p < 0.05 vs. before VLCD, n = 27
From: Caloric restriction lowers endocannabinoid tonus and improves cardiac function in type 2 diabetes

Change in AEA (a) and 2-AG (b). *p < 0.05 vs. before VLCD, n = 27